表5_通过整合生物信息学分析鉴定与上皮性卵巢癌进展和预后相关的潜在生物标志物
上皮性卵巢癌基因表达谱生物信息学分析结果,包括差异表达基因、核心基因及预后标志物等数据。

基本信息
资源简介
表5_通过整合生物信息学分析鉴定与上皮性卵巢癌进展和预后相关的潜在生物标志物
【一句话概览】
本数据集是 figshare 公开的结构化表格数据集,收录 1 个文件、合计 18.61 KB,主题涵盖 epithelial ovarian cancer、bioinformatical analysis、differentially expressed genes、prognosis、Cmap,可用于统计建模、特征工程与队列分析,CC BY 4.0 许可开放获取。
【数据集背景】
本数据集源站标题为《Table_5_Identification of Potential Biomarkers in Association With Progression and Prognosis in Epithelial Ovarian Cancer by Integrated Bioinformatics Analysis.docx》。配套论文《Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)》发表于 The Lancet(2015),DOI:10.1016/S0140-6736%2814%2962038-9。源站首次发布:2019-10-24。
【数据内容】
源站原始描述:Epithelial ovarian cancer (EOC) is one of the malignancies in women, which has the highest mortality. However, the microlevel mechanism has not been discussed in detail. The expression profiles GSE27651, GSE38666, GSE40595, and GSE66957 including 188 tumor and 52 nontumor samples were downloaded from the Gene Expression Omnibus database. The differentially expressed genes (DEGs) were filtered using R software, and we performed functional analysis using the clusterProfiler. Cytoscape software, th…
【数据结构与技术规格】
文件数 1 个,合计 18.61 KB。Table_5_Identification of Potential Biomarkers in Association With Progression and Prognosis in Epithelial Ovarian Cancer by Integrated Bioinformatics.docx:application/vnd.openxmlformats-officedocument.wordprocessingml.document,18.61 KB。数据集 DOI:10.3389/fgene.2019.01031.s009。
【主题与分类】
源站学科分类:Gene and Molecular Therapy、Biomarkers、Genetics、Genetically Modified Animals、Developmental Genetics (incl. Sex Determination)、Epigenetics (incl. Genome Methylation and Epigenomics)。主题标签:epithelial ovarian cancer、bioinformatical analysis、differentially expressed genes、prognosis、Cmap、protein–protein interaction、biomarker。
【适用方向】
结构化表格数据可直接用于统计建模、特征工程与队列分析。
【获取与许可】
源站页面:https://frontiersin.figshare.com/articles/dataset/Table_5_Identification_of_Potential_Biomarkers_in_Association_With_Progression_and_Prognosis_in_Epithelial_Ovarian_Cancer_by_Integrated_Bioinformatics_Analysis_docx/10033142
使用许可:CC BY 4.0(https://creativecommons.org/licenses/by/4.0/)。
规范引用:Liu, Jinhui; Meng, Huangyang; Li, Siyue; Shen, Yujie; Wang, Hui; Shan, Wu; et al. (2019). Table_5_Identification of Potential Biomarkers in Association With Progression and Prognosis in Epithelial Ovarian Cancer by Integrated Bioinformatics Analysis.docx. Frontiers. Dataset
【使用注意】
· 源站最后修改于 2023-06-04,引用时请注意版本时效。
下载信息
注册下载
需要注册 Kaggle 账号并登录后下载,适合需要跟踪下载记录和使用 API 的用户。
暂未开放公开下载
无需注册即可直接获取公开样本或文档,适合快速预览和评估数据集质量。
免登录有偿下载
公开数据集受托下载与技术交付服务。
提供高速下载与技术交付服务(收技术服务费,非数据销售)
暂未开放当前数据集主要来源为 Kaggle 公开托管,完整影像包建议通过原始链接或 Kaggle API 获取。
使用方式
数据集获取(Figshare)
- 源站标题:Table_5_Identification of Potential Biomarkers in Association With Progression and Prognosis in Epithelial Ovarian Cancer by Integrated Bioinformatics Analysis.docx
- DOI:10.3389/fgene.2019.01031.s009
- 发布日期:2019-10-24
- 文件数:1 个
- 文件总体积:18.61 KB
- 源站页面:https://frontiersin.figshare.com/articles/dataset/Table_5_Identification_of_Potential_Biomarkers_in_Association_With_Progression_and_Prognosis_in_Epithelial_Ovarian_Cancer_by_Integrated_Bioinformatics_Analysis_docx/10033142
命令行下载
curl -L -o "Table_5_Identification of Potential Biomarkers in Association With Progression and Prognosis in Epithelial Ovarian Cancer by Integrated Bioinformatics.docx" "https://ndownloader.figshare.com/files/18090338"
文件清单
Table_5_Identification of Potential Biomarkers in Association With Progression and Prognosis in Epithelial Ovarian Cancer by Integrated Bioinformatics.docx(18.61 KB)
文件总体积 18.61 KB(源站 API 实测)。
数据说明
Epithelial ovarian cancer (EOC) is one of the malignancies in women, which has the highest mortality. However, the microlevel mechanism has not been discussed in detail. The expression profiles GSE27651, GSE38666, GSE40595, and GSE66957 including 188 tumor and 52 nontumor samples were downloaded from the Gene Expression Omnibus database. The differentially expressed genes (DEGs) were filtered using R software, and we performed functional analysis using the clusterProfiler. Cytoscape software, the molecular complex detection plugin and database STRING analyzed DEGs to construct protein-protein interaction network. We identified 116 DEGs including 81 upregulated and 35 downregulated DEGs. Functional analysis revealed that they were significantly enriched in the extracellular region and biosynthesis of amino acids. We next identified four bioactive compounds (vorinostat, LY-294002,trichostatin A, and tanespimycin) based on ConnectivityMap. Then 114 nodes were obtained in protein–protein interaction. The three most relevant modules were detected. In addition, according to degree ≥ 10, 14 core genes including FOXM1, CXCR4, KPNA2, NANOG, UBE2C, KIF11, ZWINT, CDCA5, DLGAP5, KIF15, MCM2, MELK, SPP1, and TRIP13 were identified. Kaplan–Meier analysis, Oncomine, and Gene Expression Profiling Interactive Analysis showed that overexpression of FOXM1, SPP1, UBE2C, KIF11, ZWINT, CDCA5, UBE2C, and KIF15 was related to bad prognosis of EOC patients. CDCA5, FOXM1, KIF15, MCM2, and ZWINT were associated with stage. Receiver operating characteristic (ROC) curve showed that messenger RNA levels of these five genes exhibited better diagnostic efficiency for normal and tumor tissues. The Human Protein Atlas database was performed. The protein levels of these five genes were significantly higher in tumor tissues compared with normal tissues. Functional enrichment analysis suggested that all the hub genes played crucial roles in citrate cycle tricarboxylic acid cycle. Furthermore, the univariate and multivariate Cox proportional hazards regression showed that ZWINT was independent prognostic indictor among EOC patients. The genes and pathways discovered in the above studies may open a n
许可
CC BY 4.0
引用
学术使用请引用 DOI 10.3389/fgene.2019.01031.s009(source: https://frontiersin.figshare.com/articles/dataset/Table_5_Identification_of_Potential_Biomarkers_in_Association_With_Progression_and_Prognosis_in_Epithelial_Ovarian_Cancer_by_Integrated_Bioinformatics_Analysis_docx/10033142)。
数据缺失?
依托陕西、四川两大基地,我们与超过十家三甲医院建立直接合作关系,覆盖合规授权、采集治理、专业标注、数据交付的全流程,为AI医疗团队提供即拿即用的高质量临床数据。
⚡️ 需要数据支持或标注服务?立即联系我们获取专业方案。




